[page 7]

Product Name

Molecular Formula

Sequence

C₄₆H₈₄N₁₆O₁₂S

H-QMRPVSRVL-OH

C₄₉H₈₂N₁₂O₁₁S

H-VMAPRTLFL-OH

C₄₉H₇₅N₁₁O₁₇

H-VTEHDTLLY-OH

HIV TAT (48-57)

C₅₅H₁₀₉N₃₁O₁₂

H-RRRQRRKKRG-OH

C₉₄H₁₅₇N₃₅O₁₆

H-RFGRFLRKIRRFRPK-OH

C₂₆H₄₈N₁₂O₆S

cyclo(LARGRC), end-collateral amide bond into a ring

C₅₉H₁₁₀N₂₄O₁₆S₂

H-KCVRQNNKRVCK-OH

pHLA/MAGE-A10-9

C₄₅H₆₇N₁₁O₁₅S

H-GLYDGMEHL-OH

C₁₉₆H₃₁₇N₄₃O₆₄S

H-SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-OH

C₅₀H₆₇N₉O₁₅S₂

H-CLSYYPSYC-OH

C₄₅H₇₄N₁₆O₁₃S₂

H-HMTEVVRHC-OH

C₅₂H₉₆N₁₄O₁₃

H-RLQTALLVVL-OH

NY-ESO-1 (157-165)/ESO 9C

C₄₉H₇₉N₁₁O₁₃S₂

H-SLLMWITQC-OH

C₄₇H₇₈N₁₀O₁₄

H-ALYDVVSKL-OH

C₂₅H₄₁N₉O₁₀

Ac-SHAVSS-NH2

C₅₈H₇₆N₁₀O₁₃

H-FEFKFEFK-OH

C₄₅H₇₁N₁₃O₁₂S

H-RVNEWVIC-OH

C₄₈H₇₄N₁₂O₁₆

H-TIHDSIQYV-OH

NDC80 HLA-A*02/ALNEQIARL

C₄₄H₇₈N₁₄O₁₄

H-ALNEQIARL-OH

Eyeseryl/Acetyl Tetrapeptide-5

C₂₀H₂₈N₈O₇

Ac-bAla-HSH

C₃₀H₅₄N₁₆O₁₀S₂

H-CGRRAGGSC-NH2

C₇₁H₁₁₆N₂₂O₁₈S

H-FRNLAYGRTCVLGK-OH

C₄₄H₅₉N₇O₈S

H-FFLLFGC-OH

C₆₂H₁₀₇N₁₉O₁₈S₃

H-KMHTASLSQPLMGC-NH2

C₂₀H₃₃N₅O₉

Ac-SDKP-OH

C₁₁₄H₁₅₆N₂₄O₂₈

Ac-DWFKAFYDKVAEKFKEAF-NH2

C₃₆H₆₄N₁₂O₁₁S₃

H-CVPMSMRGG-OH

C₅₀H₇₈N₁₂O₁₃

H-NLTHVLYPV-OH

Mesothelin 530–538 (HLA-A*02:01)

C₄₄H₇₇N₉O₁₃

H-VLPLTVAEV-OH

C₆₇H₉₄N₁₄O₁₉

H-EEFKWKFKEE-OH

C₆₂H₁₀₂N₁₈O₂₀

H-FEAQKAKANKAVD-OH

C₁₀₅H₁₇₉N₂₇O₂₂

H-KLKKIAQKIKNFFQKLVP-OH

C₇₄H₁₂₆N₂₄O₁₉S

H-CKHHLGLEEPKKLR-OH

C₁₅₈H₂₆₄N₃₈O₄₂S₃

H-ILMQYIKANSKFIGIPMGLPQSIALSSLMVAQ-OH

C₈₄H₁₃₃N₂₅O₂₈S

H-IVMPESSGNPNAVNPAGYR-OH

C₅₉H₁₀₀N₂₄O₁₇

H-RRQPPRSISSHP-OH

C₃₀H₄₀N₈O₈

H-RGDFF-OH

PDL101/PDL1 15–23

C₄₆H₇₆N₁₀O₁₃

H-LLNAFTVTV-OH

C₃₆H₆₂N₈O₁₄

H-DLTAGLLE-OH